These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24387321)

  • 1. Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis.
    Wang YZ; Tian FF; Yan M; Zhang JM; Liu Q; Lu JY; Zhou WB; Yang H; Li J
    Clin Exp Immunol; 2014 May; 176(2):207-21. PubMed ID: 24387321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
    Cron MA; Payet CA; Fayet OM; Maillard S; Truffault F; Fadel E; Guihaire J; Berrih-Aknin S; Liston A; Le Panse R
    J Neuroinflammation; 2020 Oct; 17(1):294. PubMed ID: 33032631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis.
    Allman W; Saini SS; Tuzun E; Christadoss P
    Cell Immunol; 2011; 271(2):292-8. PubMed ID: 21861992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.
    Zhang J; Jia G; Liu Q; Hu J; Yan M; Yang B; Yang H; Zhou W; Li J
    Immunology; 2015 Jan; 144(1):56-67. PubMed ID: 24962817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of miR-146a in myasthenia gravis.
    Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J
    Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
    Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
    J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
    Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P
    Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX; Xiao BG; Yu LY; van der Meide PH; Link H
    J Neuroimmunol; 2001 Feb; 113(1):10-8. PubMed ID: 11137572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
    Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
    J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
    Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.
    Poussin MA; Goluszko E; Hughes TK; Duchicella SI; Christadoss P
    J Neuroimmunol; 2000 Nov; 111(1-2):152-60. PubMed ID: 11063833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.
    Cufi P; Dragin N; Weiss JM; Martinez-Martinez P; De Baets MH; Roussin R; Fadel E; Berrih-Aknin S; Le Panse R
    Ann Neurol; 2013 Feb; 73(2):281-93. PubMed ID: 23280437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.
    Yang H; Kala M; Scott BG; Goluszko E; Chapman HA; Christadoss P
    J Immunol; 2005 Feb; 174(3):1729-37. PubMed ID: 15661938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Huang J; Olsson T; He B; Link H
    J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.